377 related articles for article (PubMed ID: 14520627)
1. Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients.
Kalantar-Zadeh K; McAllister CJ; Lehn RS; Lee GH; Nissenson AR; Kopple JD
Am J Kidney Dis; 2003 Oct; 42(4):761-73. PubMed ID: 14520627
[TBL] [Abstract][Full Text] [Related]
2. Combined high serum ferritin and low iron saturation in hemodialysis patients: the role of inflammation.
Rambod M; Kovesdy CP; Kalantar-Zadeh K
Clin J Am Soc Nephrol; 2008 Nov; 3(6):1691-701. PubMed ID: 18922994
[TBL] [Abstract][Full Text] [Related]
3. Relationship between erythropoietin responsiveness, insulin resistance, and malnutrition-inflammation-atherosclerosis (MIA) syndrome in hemodialysis patients with diabetes.
Abe M; Okada K; Maruyama T; Maruyama N; Matsumoto K; Soma M
Int J Artif Organs; 2011 Jan; 34(1):16-25. PubMed ID: 21298620
[TBL] [Abstract][Full Text] [Related]
4. Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients.
Kalantar-Zadeh K; Rodriguez RA; Humphreys MH
Nephrol Dial Transplant; 2004 Jan; 19(1):141-9. PubMed ID: 14671049
[TBL] [Abstract][Full Text] [Related]
5. Effect of protein-energy malnutrition on erythropoietin requirement in maintenance hemodialysis patients.
Akgul A; Bilgic A; Sezer S; Ozdemir FN; Olcay I; Arat Z; Haberal M
Hemodial Int; 2007 Apr; 11(2):198-203. PubMed ID: 17403171
[TBL] [Abstract][Full Text] [Related]
6. A Prospective, Self-Controlled Pilot Study of the Efficacy of Roxadustat for Erythropoietin Hyporesponsiveness in Patients Requiring Chronic Ambulatory Peritoneal Dialysis.
Chen J; Li Z; Zhang H; Hu J; Wang J; Zhou H; Liu Y; Liu J; Yi B; Zhang W
J Ren Nutr; 2022 Sep; 32(5):595-604. PubMed ID: 34756787
[TBL] [Abstract][Full Text] [Related]
7. Association of malnutrition-inflammation complex and responsiveness to erythropoiesis-stimulating agents in long-term hemodialysis patients.
Rattanasompattikul M; Molnar MZ; Zaritsky JJ; Hatamizadeh P; Jing J; Norris KC; Kovesdy CP; Kalantar-Zadeh K
Nephrol Dial Transplant; 2013 Jul; 28(7):1936-45. PubMed ID: 23045431
[TBL] [Abstract][Full Text] [Related]
8. Serum-soluble Fas and serum levels of erythropoietin in chronic kidney disease.
Góes MA; Dalboni MA; Manfredi SR; Cendoroglo MS; Batista MC; Canziani ME; Balakrishnan VS; Pereira BJ; Draibe SA; Cendoroglo M
Clin Nephrol; 2010 Jan; 73(1):7-13. PubMed ID: 20040346
[TBL] [Abstract][Full Text] [Related]
9. Adverse events in chronic hemodialysis patients receiving intravenous iron dextran--a comparison of two products.
McCarthy JT; Regnier CE; Loebertmann CL; Bergstralh EJ
Am J Nephrol; 2000; 20(6):455-62. PubMed ID: 11146312
[TBL] [Abstract][Full Text] [Related]
10. Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients.
Kalantar-Zadeh K; Kopple JD; Humphreys MH; Block G
Nephrol Dial Transplant; 2004 Jun; 19(6):1507-19. PubMed ID: 15069177
[TBL] [Abstract][Full Text] [Related]
11. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
Attallah N; Osman-Malik Y; Frinak S; Besarab A
Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
[TBL] [Abstract][Full Text] [Related]
12. Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients.
Taylor JE; Peat N; Porter C; Morgan AG
Nephrol Dial Transplant; 1996 Jun; 11(6):1079-83. PubMed ID: 8671972
[TBL] [Abstract][Full Text] [Related]
13. Association between Serum Magnesium and Erythropoietin Responsiveness in Hemodialysis Patients: A Cross-Sectional Study.
Yu L; Song J; Lu X; Zu Y; Li H; Wang S
Kidney Blood Press Res; 2019; 44(3):354-361. PubMed ID: 31189174
[TBL] [Abstract][Full Text] [Related]
14. Effect of an intravenous iron dextran regimen on iron stores, hemoglobin, and erythropoietin requirements in hemodialysis patients.
Park L; Uhthoff T; Tierney M; Nadler S
Am J Kidney Dis; 1998 May; 31(5):835-40. PubMed ID: 9590194
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin requirements increase following hospitalization in end-stage renal disease patients.
Yaqub MS; Leiser J; Molitoris BA
Am J Nephrol; 2001; 21(5):390-6. PubMed ID: 11684801
[TBL] [Abstract][Full Text] [Related]
16. Improvement of nutritional status in patients receiving maintenance hemodialysis after correction of renal anemia with recombinant human erythropoietin.
Tarng DC; Huang TP; Doong TI
Nephron; 1998; 78(3):253-9. PubMed ID: 9546682
[TBL] [Abstract][Full Text] [Related]
17. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin increases erythropoietin-stimulating agent hyporesponsiveness in maintenance hemodialysis patients: role of anti-inflammation effects.
Chiang CK; Yang SY; Peng YS; Hsu SP; Pai MF; Huang JW; Hung KY; Wu KD
Am J Nephrol; 2009; 29(5):392-7. PubMed ID: 18974640
[TBL] [Abstract][Full Text] [Related]
19. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
[TBL] [Abstract][Full Text] [Related]
20. Quotidian nocturnal hemodialysis improves cytokine profile and enhances erythropoietin responsiveness.
Yuen D; Richardson RM; Fenton SS; McGrath-Chong ME; Chan CT
ASAIO J; 2005; 51(3):236-41. PubMed ID: 15968953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
